Go to the article
- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Alternative Capital and Credit Funds
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions
- Middle East and Islamic Finance and Investment
- Private Equity
- Real Estate
- Securitization
- Tax
- Technology and Emerging Companies
- Government Matters
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Insurance Coverage and Recovery
- Intellectual Property, Patent, Trademark and Copyright Litigation
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries
- Careers
- News & Insights
- About
- Languages
News & Insights
Article
July 1, 2019 - Source: Intellectual Property & Technology Law Journal
FDA Proposes Regulatory Framework for Artificial Intelligence/Machine Learning Software as a Medical Device
Featured Lawyers
D. Kyle Sampson
Washington, D.C.
Lisa M. Dwyer
Washington, D.C.
Elaine H. Tseng
San Francisco
Bev H. Lorell, MD
Washington, D.C.
Krishna Kavi
Washington, D.C.
Close
Featured Lawyers
D. Kyle Sampson
Washington, D.C.
Lisa M. Dwyer
Washington, D.C.
Elaine H. Tseng
San Francisco
Bev H. Lorell, MD
Washington, D.C.
Krishna Kavi
Washington, D.C.